Literature DB >> 18242740

Current trends in the management of heart disease in pregnancy.

Stephanie L Curtis1, Joanna Marsden-Williams, Charlotte Sullivan, Susan M Sellers, Johanna Trinder, Mark Scrutton, A Graham Stuart.   

Abstract

BACKGROUND: The management of heart disease in pregnancy is highly specialized. Guidelines are based on observational studies. This paper describes our experience of these patients, including adverse cardiac events, adherence to guidelines, and areas of suboptimal management.
METHODS: Patients referred to the service between 01/05/1999 and 30/06/2005 were identified using clinic lists and keyword searches in databases. A list of 40 management standards was created from European Society of Cardiology and the Confidential Enquiry into Maternal and Child Health guidelines. Adherence to these was recorded and adverse cardiac events noted.
RESULTS: There were 177 pregnancies in 155 women with a mean age of 28+/-6 years. Service referrals increased linearly throughout the study period. Of 131 cardiac pregnancies 101 had congenital heart disease (77.1%). Pulmonary oedema, deteriorating functional class, sustained arrhythmia or cardiac intervention occurred in 13 pregnancies (10.2%), though not always in high risk cases. Management guidelines were largely followed, though areas of suboptimal management included lack of pre-conception advice and inadequate post-partum follow-up. Controversial areas include the use of beta-blockade in coarctation of the aorta and the use of elective Caesarean section in high risk patients.
CONCLUSIONS: Cardiac pregnancies are increasing, mainly due to the rise in patients with congenital heart disease. Some patients will experience adverse cardiac events, including low risk patients. Pre-conception advice and post-partum follow-up should be improved. In the absence of prospective studies, management is likely to be driven by observational studies.

Entities:  

Mesh:

Year:  2008        PMID: 18242740     DOI: 10.1016/j.ijcard.2007.11.084

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  [Application of sevoflurane and laryngeal mask in cesarean section in women with heart disease].

Authors:  Zhi-Peng Wang; Jue Ma; Sheng Wang; Li-Na Yu; Jin-Feng Wei; Jin-Dong Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20

2.  Accuracy of risk prediction scores in pregnant women with congenital heart disease.

Authors:  Yuli Y Kim; Leah A Goldberg; Katherine Awh; Tanmay Bhamare; David Drajpuch; Adi Hirshberg; Sara L Partington; Rachel Rogers; Emily Ruckdeschel; Lynda Tobin; Morgan Venuti; Lisa D Levine
Journal:  Congenit Heart Dis       Date:  2019-02-06       Impact factor: 2.007

Review 3.  Is vaginal delivery or caesarean section the safer mode of delivery in patients with adult congenital heart disease?

Authors:  Victoria Asfour; Michael O Murphy; Rizwan Attia
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

Review 4.  Management of pregnant and postnatal women with pre-existing diabetes or cardiac disease using multi-disciplinary team models of care: a systematic review.

Authors:  Debra Bick; Sarah Beake; Lucy Chappell; Khaled M Ismail; David R McCance; James S A Green; Cath Taylor
Journal:  BMC Pregnancy Childbirth       Date:  2014-12-20       Impact factor: 3.007

Review 5.  Heart Disease and Pregnancy.

Authors:  Reza Ashrafi; Stephanie L Curtis
Journal:  Cardiol Ther       Date:  2017-07-05

6.  Cardiac conditions in pregnancy and the role of midwives: A discussion paper.

Authors:  Sandra Millington; Judith Magarey; Gustaaf A Dekker; Robyn A Clark
Journal:  Nurs Open       Date:  2019-04-01

7.  Caring for Pregnant Women with Rheumatic Heart Disease: A Qualitative Study of Health Service Provider Perspectives.

Authors:  Geraldine Vaughan; Angela Dawson; Michael Peek; Jonathan Carapetis; Vicki Wade; Elizabeth Sullivan
Journal:  Glob Heart       Date:  2021-12-22

8.  Risk Prediction of Cardiovascular Complications in Pregnant Women With Heart Disease.

Authors:  Luciana Carvalho Martins; Claudia Maria Vilas Freire; Carolina Andrade Bragança Capuruçu; Maria do Carmo Pereira Nunes; Cezar Alencar de Lima Rezende
Journal:  Arq Bras Cardiol       Date:  2016-03-08       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.